New research published in the Journal of the American College of Cardiology shows the use of drug-coated balloons is an optimal approach compared to bare metal stents in treating femoropopliteal lesions.
Artificial intelligence can improve diagnosis and treatment for patients, but first the AI-enabled clinical tools have to be easily available and used.
The destruction of red blood cells, or mechanical hemolysis, is an inevitable complication of interventional devices, so scientists want to gain a better understanding of the phenomenon. In Physics of Fluids, researchers develop a red blood cell destruction model based on simulations of dissipative particle dynamics within a high shear flow. The team discovered that acceleration during shearing is a major factor in red blood cell destruction, beyond exposure time and shear stress. They recommend adding a flow buffer structure to the structural design of ventricular assist devices to reduce part of the hemolysis caused by shear acceleration.
MIM Software Inc., a leading global provider of medical imaging software, announced today it has received approval from Health Canada for its AI auto-contouring solution, Contour ProtégéAI™.
A large-scale comparison of direct oral anticoagulants (blood thinners), commonly prescribed for irregular heartbeats, has identified the drug with the lowest risk of bleeding, in a new study led by UCL researchers.
A Roundup of the Latest Medical Discoveries and Faculty News at Cedars-Sinai
U.S. deaths from heart disease spiked in 2020 at the start of the COVID-19 pandemic after a steady decline from 2010 to 2019, reversing a public health success, according to preliminary research to be presented at the American Heart Association’s Scientific Sessions 2022.
RUDN doctors have found genetic factors that increase the risk of recurrent vascular stenosis after stent placement. The data obtained will help to adjust the treatment and choose an individual approach for patients with coronary heart disease.
Will also serve as the first-ever Dr. Valentin Fuster Professor of Cardiovascular Medicine
Two minute bursts of vigorous activity totalling 15 minutes a week are associated with a reduced risk of death, according to research published today in European Heart Journal, a journal of the European Society of Cardiology (ESC).1
W. L. Gore & Associates initiates its GORE® VIAFORT Device Pivotal Clinical Study for the treatment of inferior vena cava occlusive disease.
Ahead of World Stroke Day, Oct. 29, investigators from the Department of Neurology at Cedars-Sinai have new information on stroke-related health disparities.
In acknowledgment of her research advancing the field of cardiovascular science, UTHealth Houston’s Louise McCullough, MD, PhD, has been honored with the 2022 American Heart Association Basic Research Prize.
Here are some of the latest articles that have been added to the Drugs and drug abuse channel.
Elite young athletes are set to benefit from a novel screening tool with the potential to change clinical practice by ruling out a serious heart condition frequently misdiagnosed.
A global study of over 28,000 people has provided the strongest evidence to date that lowering blood pressure in later life can cut the risk of dementia.
Thousands of people have new hope for treatment of thoracic aortic arch disease and UH Harrington Heart & Vascular Institute is at the forefront of studying the safety and efficacy of this new procedure.
Chronic heart failure causes the cell’s powerhouses to dysfunction, in part due to overconsumption of an important intermediary compound in energy production.
Researchers at Vanderbilt University Medical Center have found that the change in a single letter of the genetic code promotes, in a mouse model, the development of inflammation, high blood pressure and resulting kidney damage.
New data analysis from the Smidt Heart Institute at Cedars-Sinai found that deaths from heart attacks rose significantly during pandemic surges, including the COVID-19 Omicron surges, overall reversing a heart-healthier pre-pandemic trend.
The latest articles that have been added to the Environmental Health channel.
The Smidt Heart Institute at Cedars-Sinai has selected leading vascular surgeon Donald Baril, MD, as director of the Vascular Surgery Fellowship Program. Baril, who joined Cedars-Sinai in 2020, aims to advance the academic medical center’s excellence in vascular care, research and education for current and future fellows.
Quando falamos em AVCs, cada segundo é importante. Especialistas da Mayo Clinic explicam como reconhecer os sinais de um AVC e como reduzir o seu risco. “Dizemos com frequência que o ‘tempo é valioso para o cérebro,’ o que significa que, quanto mais rápido for restabelecido o fluxo sanguíneo para ele, melhores serão os resultados para o paciente,” afirma o Dr. James Meschia, neurologista da Mayo Clinic, na Flórida.
مدينة روتشستر، ولاية مينيسوتا. — كل ثانية مهمة عند الحديث عن السكتات الدماغية. حيث يشرح أحد خبراء مايو كلينك كيفية التعرف على مؤشرات السَّكتة الدماغية وكيفية التقليل من مخاطر حدوثها. "نحن نقول دائمًا إن (الوقت من ذهب)، أي أنه كلما أسرعنا في استعادة تدفق الدم إلى الدماغ، صارت النتائج أفضل بالنسبة للمريض" - كما يقول جيمس ميسكيا، دكتور الطب، طبيب الأعصاب في مايو كلينك في فلوريدا.
A mouse study by Kristin Stanford, a physiology and cell biology researcher with The Ohio State University College of Medicine at the Wexner Medical Center, provides new ways to determine how maternal and paternal exercise improve metabolic health of offspring.
罗切斯特，明尼苏达州— 当卒中来袭时，每一秒都很重要。妙佑医疗国际专家解释了如何识别卒中的体征以及如何降低卒中风险。“我们常说‘时间就是大脑’，意思是大脑的血流能越早恢复，患者的结果就越好，”妙佑医疗国际佛罗里达州院区的神经科医生James Meschia医学博士说。
Cuando se trata de accidentes cerebrovasculares , cada segundo cuenta. Los expertos de Mayo Clinic explican cómo reconocer los signos de un accidente cerebrovascular y cómo reducir el riesgo de que se produzcan. "A menudo decimos 'el tiempo es cerebro' para referirnos a que cuanto antes podamos restaurar el flujo de sangre al cerebro, mejores serán los resultados para el paciente," dice el Dr. James Meschia, neurólogo de Mayo Clinic en Florida .
When it comes to strokes, every second counts. Mayo Clinic experts explain how to recognize the signs of a stroke and how to reduce stroke risk.
Researchers at Columbia University Mailman School of Public Health evaluated an expanded measure of cardiovascular health (CVH) that includes sleep as an eighth metric, in relation to cardiovascular disease risk.
For decades, scientists in Berlin have been researching a strange hereditary condition that results in half the members of certain families having unusually short fingers and extremely high blood pressure.
A team at Children’s Hospital Los Angeles recently became the first in the world to use a novel, basket-shaped retrieval device to successfully remove a large right atrial thrombus (blood clot).
After 11 years spent in medical school, residency and fellowships, Elizabeth Chou, MD, a vascular surgeon who recently joined the Smidt Heart Institute at Cedars-Sinai, has earned her dream career. And she has no plans of stopping there. She’s on a path toward ensuring women in vascular surgery are represented—as incoming physicians and as patients.
Vasa Therapeutics, Inc., a preclinical stage company developing first-in-class treatments for cardiovascular indications with limited or no available therapies, today announced two upcoming poster presentations showing data on the company's lead clinical candidate, VS-041, a selective matrix metalloprotease (MMP) inhibitor for treatment of heart failure with preserved ejection fraction (HFpEF) and the discovery of novel calcium/calmodulin-dependent protein kinase II delta (CaMKIIδ) inhibitors for treatment of β-blocker resistant arrythmias, at the American Heart Association (AHA) Scientific Sessions November 5 – 7 in Chicago, IL.
The new study showed apixaban is superior to rivaroxaban against stroke or systemic embolism in patients with atrial fibrillation and valvular heart disease
Getting less than five hours of sleep in mid-to-late life could be linked to an increased risk of developing at least two chronic diseases, finds a new study led by UCL researchers.
Currently, the U.S. leads western nations in infant mortality and cardiac birth defects are a leading cause. New research harnesses the power of AI to detect dangerous cardiac abnormalities prenatally. Resulting medical protocols implemented at birth in those at-risk could go a long way toward saving lives.
Studies have suggested that psoriasis is an independent risk factor for heart attack in the general population, but investigators have made the surprising finding that in people who also have end-stage renal disease, which shares many risk factors with heart disease, it is not.
New York Institute of Technology's Center for Esports Medicine announces a research collaboration with GE Healthcare that seeks to analyze the lean body mass of competitive esport athletes and help establish the sport’s first body composition benchmarks.
Mount Sinai Health System’s globally acclaimed cardiologist Valentin Fuster, MD, PhD, has been named President of Mount Sinai Heart, a newly created position, effective Sunday, January 1, 2023. Dr. Fuster will continue in his roles as Physician-in-Chief of The Mount Sinai Hospital and as the Richard Gorlin, MD/Heart Research Foundation Professor at the Icahn School of Medicine at Mount Sinai.
A large population-based study of patients with atrial fibrillation (AF) and valvular heart disease (VHD) found that use of apixaban was associated with a lower rate of ischemic stroke or systemic embolism and a lower rate of intracranial or gastrointestinal (GI) bleeding compared with rivaroxaban. The authors say clinicians should consider these findings when selecting anticoagulants in this patient population. The study is published in Annals of Internal Medicine.
For men and women, the risk factors for cardiovascular disease are largely the same, an extensive global study involving University of Gothenburg researchers shows.
Due to longstanding systemic inequities, Hispanic and Black adults are generally less satisfied with their interaction with physicians and may not receive the same quality of care.
Asher Kimchi, MD, clinical chief of Cardiology, vice-clinical chief of the Department of Medicine, and founder and co-medical director of the Preventive and Consultative Heart Center of Excellence at Smidt Heart Institute, passed away Friday, Oct. 7. He was 76.
The statistically and clinically significant results of the pilot program– one of the first in the country – showed that enrollment in Ochsner Digital Medicine brought nearly half of all out-of-control Hypertension patients under control at only 90 days.
Levels of the immune protein suPAR are high in patients with heart failure and predict both heart failure and death, a new study suggests. Beyond that, when suPAR is combined with BNP, a downstream indicator of heart failure, the ability to predict such risks gets even stronger.
A study by UChicago researchers identifies the role that the BNIP3 protein plays in the development of fatty liver and liver cancer.
The October issue of SLAS Discovery is now available open access on ScienceDirect.
Nationally recognized cardiothoracic surgeon, Douglas R. Johnston, MD, has been named surgical director of Northwestern Medicine’s Bluhm Cardiovascular Institute and chief of the division of cardiac surgery at Northwestern Memorial Hospital and Northwestern University Feinberg School of Medicine.
For the approximately 8.5 million people in the U.S. living with peripheral artery disease (PAD – pronounced P-A-D), which is narrowed or clogged arteries in the legs, treatment decisions and criteria for success should be led by their symptoms and self-reported quality of life, according to a new American Heart Association scientific statement published today in the Association’s flagship, peer-reviewed journal Circulation.
Global health has paid a deadly price for not using simple, low-cost blood pressure lowering drugs, statins and aspirin widely in the form of a single pill, also known as the polypill, say two leading cardiologists in a commentary published in The Lancet.
RSS
Medicine keyboard_arrow_right
Sciencekeyboard_arrow_right
Life keyboard_arrow_right
Business keyboard_arrow_right
Journal News keyboard_arrow_right
By Location keyboard_arrow_right
Meetings, Grants, and Events keyboard_arrow_right
